Kewaunee Scientific shareholders re-elect directors and approve auditor at annual meeting

Kewaunee Scientific Corporation (NASDAQ:KEQU), a $170 million market cap company currently trading at $57.68, held its Annual Meeting of Shareholders on Wednesday. The company, which has shown impressive revenue growth of 18% over the last twelve months and maintains a "GREAT" financial health rating according to InvestingPro, gathered shareholders to vote on several key matters.

Margaret B. Pyle and Donald F. Shaw were re-elected as Class III directors for three-year terms. Pyle received 1,633,067 votes in favor and 189,229 votes withheld, while Shaw received 1,730,171 votes in favor and 92,125 votes withheld. Both nominees had 537,449 non-voting shares recorded. InvestingPro analysis shows the company has demonstrated strong returns over both the last three months and the past decade, suggesting effective leadership.

Shareholders ratified the appointment of Forvis Mazars, LLP as the company’s independent auditors for the 2026 fiscal year. The vote was 2,356,636 in favor, 2,119 against, and 990 abstentions.

An advisory vote approved the compensation of the company’s named executive officers, with 1,448,991 votes for, 103,177 against, 270,128 abstentions, and 537,449 non-votes.

Shareholders also voted on the frequency of future advisory votes on executive compensation. The results were 1,512,884 for annual votes, 1,194 for every two years, 306,985 for every three years, 1,233 abstentions, and 537,449 non-votes. Following the board’s recommendation and the majority vote, the company will continue to hold advisory votes on executive compensation annually.

All information is based on a press release statement included in the company’s recent SEC filing.

In other recent news, Kewaunee Scientific Corporation reported strong fourth-quarter earnings, significantly surpassing previous results. The company posted adjusted earnings per share of $1.95 for the quarter ending April 30, 2025. Revenue for the same period saw a substantial increase, rising 36.1% year-over-year to $77.15 million. These earnings results have been a major development for the company. The financial performance indicates a robust quarter for Kewaunee Scientific, reflecting positive business momentum. Investors and analysts will likely be paying close attention to these figures as they assess the company’s future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.